nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—PTGS1—kidney cancer	0.334	1	CbGaD
Rosiglitazone—SLCO1B1—Pazopanib—kidney cancer	0.07	0.177	CbGbCtD
Rosiglitazone—CYP2D6—Temsirolimus—kidney cancer	0.0359	0.0909	CbGbCtD
Rosiglitazone—CYP2C8—Pazopanib—kidney cancer	0.0296	0.0749	CbGbCtD
Rosiglitazone—ALB—Erlotinib—kidney cancer	0.0273	0.0692	CbGbCtD
Rosiglitazone—CYP1A2—Pazopanib—kidney cancer	0.0229	0.058	CbGbCtD
Rosiglitazone—CYP2C9—Capecitabine—kidney cancer	0.0215	0.0545	CbGbCtD
Rosiglitazone—CYP2C8—Erlotinib—kidney cancer	0.0211	0.0534	CbGbCtD
Rosiglitazone—CYP2C8—Paclitaxel—kidney cancer	0.0193	0.0489	CbGbCtD
Rosiglitazone—CYP2D6—Pazopanib—kidney cancer	0.0189	0.0478	CbGbCtD
Rosiglitazone—CYP2C8—Sorafenib—kidney cancer	0.0172	0.0435	CbGbCtD
Rosiglitazone—CYP1A2—Erlotinib—kidney cancer	0.0164	0.0414	CbGbCtD
Rosiglitazone—CYP2C19—Sorafenib—kidney cancer	0.0144	0.0365	CbGbCtD
Rosiglitazone—CYP2C9—Paclitaxel—kidney cancer	0.0135	0.0341	CbGbCtD
Rosiglitazone—CYP2D6—Erlotinib—kidney cancer	0.0135	0.0341	CbGbCtD
Rosiglitazone—CYP1A2—Sorafenib—kidney cancer	0.0133	0.0336	CbGbCtD
Rosiglitazone—CYP2C9—Sorafenib—kidney cancer	0.012	0.0303	CbGbCtD
Rosiglitazone—CYP2D6—Sorafenib—kidney cancer	0.011	0.0277	CbGbCtD
Rosiglitazone—CYP2D6—Vinblastine—kidney cancer	0.0108	0.0274	CbGbCtD
Rosiglitazone—CYP2D6—Doxorubicin—kidney cancer	0.00665	0.0168	CbGbCtD
Rosiglitazone—PPARG—nephron—kidney cancer	0.00536	0.149	CbGeAlD
Rosiglitazone—CYP2C19—urine—kidney cancer	0.00325	0.0903	CbGeAlD
Rosiglitazone—CYP1A2—urine—kidney cancer	0.00265	0.0737	CbGeAlD
Rosiglitazone—ACSL4—nephron tubule—kidney cancer	0.00257	0.0715	CbGeAlD
Rosiglitazone—PPARG—Everolimus—Temsirolimus—kidney cancer	0.00252	1	CbGdCrCtD
Rosiglitazone—CYP2C9—urine—kidney cancer	0.00252	0.07	CbGeAlD
Rosiglitazone—ACSL4—renal system—kidney cancer	0.00234	0.065	CbGeAlD
Rosiglitazone—ACSL4—cortex of kidney—kidney cancer	0.0022	0.0612	CbGeAlD
Rosiglitazone—ACSL4—gonad—kidney cancer	0.0021	0.0583	CbGeAlD
Rosiglitazone—ACSL4—cardiac atrium—kidney cancer	0.00209	0.0582	CbGeAlD
Rosiglitazone—CYP2D6—urine—kidney cancer	0.00189	0.0525	CbGeAlD
Rosiglitazone—Pioglitazone—PTGS1—kidney cancer	0.00138	1	CrCbGaD
Rosiglitazone—SLCO1B1—renal system—kidney cancer	0.00122	0.0339	CbGeAlD
Rosiglitazone—SLCO1B1—kidney—kidney cancer	0.00118	0.0328	CbGeAlD
Rosiglitazone—PPARG—renal system—kidney cancer	0.00105	0.0292	CbGeAlD
Rosiglitazone—PPARG—kidney—kidney cancer	0.00102	0.0283	CbGeAlD
Rosiglitazone—CYP2C8—renal system—kidney cancer	0.000694	0.0193	CbGeAlD
Rosiglitazone—CYP2C8—kidney—kidney cancer	0.000671	0.0186	CbGeAlD
Rosiglitazone—CYP1A2—renal system—kidney cancer	0.000649	0.018	CbGeAlD
Rosiglitazone—PTGS1—renal system—kidney cancer	0.000562	0.0156	CbGeAlD
Rosiglitazone—PTGS1—kidney—kidney cancer	0.000544	0.0151	CbGeAlD
Rosiglitazone—PTGS1—cardiac atrium—kidney cancer	0.000504	0.014	CbGeAlD
Rosiglitazone—CYP2D6—renal system—kidney cancer	0.000462	0.0129	CbGeAlD
Rosiglitazone—CYP2D6—kidney—kidney cancer	0.000447	0.0124	CbGeAlD
Rosiglitazone—Anaphylactic shock—Sorafenib—kidney cancer	0.000253	0.00149	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Paclitaxel—kidney cancer	0.000253	0.00149	CcSEcCtD
Rosiglitazone—Leukopenia—Dactinomycin—kidney cancer	0.000253	0.00149	CcSEcCtD
Rosiglitazone—Diarrhoea—Pazopanib—kidney cancer	0.000253	0.00149	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Everolimus—kidney cancer	0.000252	0.00148	CcSEcCtD
Rosiglitazone—Myocardial infarction—Paclitaxel—kidney cancer	0.000252	0.00148	CcSEcCtD
Rosiglitazone—Infection—Sorafenib—kidney cancer	0.000252	0.00148	CcSEcCtD
Rosiglitazone—Fatigue—Everolimus—kidney cancer	0.000252	0.00148	CcSEcCtD
Rosiglitazone—Constipation—Vinblastine—kidney cancer	0.000251	0.00148	CcSEcCtD
Rosiglitazone—Constipation—Everolimus—kidney cancer	0.00025	0.00147	CcSEcCtD
Rosiglitazone—Immune system disorder—Gemcitabine—kidney cancer	0.000249	0.00146	CcSEcCtD
Rosiglitazone—Nervous system disorder—Sorafenib—kidney cancer	0.000248	0.00146	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Sorafenib—kidney cancer	0.000248	0.00146	CcSEcCtD
Rosiglitazone—Rash—Temsirolimus—kidney cancer	0.000247	0.00146	CcSEcCtD
Rosiglitazone—Dermatitis—Temsirolimus—kidney cancer	0.000247	0.00146	CcSEcCtD
Rosiglitazone—Headache—Temsirolimus—kidney cancer	0.000246	0.00145	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Capecitabine—kidney cancer	0.000244	0.00144	CcSEcCtD
Rosiglitazone—Dizziness—Pazopanib—kidney cancer	0.000244	0.00144	CcSEcCtD
Rosiglitazone—Back pain—Vincristine—kidney cancer	0.000244	0.00144	CcSEcCtD
Rosiglitazone—Oedema—Sunitinib—kidney cancer	0.000244	0.00144	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000243	0.00143	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Paclitaxel—kidney cancer	0.000243	0.00143	CcSEcCtD
Rosiglitazone—Fatigue—Erlotinib—kidney cancer	0.000243	0.00143	CcSEcCtD
Rosiglitazone—Infection—Sunitinib—kidney cancer	0.000242	0.00143	CcSEcCtD
Rosiglitazone—Sinusitis—Paclitaxel—kidney cancer	0.000241	0.00142	CcSEcCtD
Rosiglitazone—Constipation—Erlotinib—kidney cancer	0.000241	0.00142	CcSEcCtD
Rosiglitazone—Myalgia—Dactinomycin—kidney cancer	0.000241	0.00142	CcSEcCtD
Rosiglitazone—Nervous system disorder—Sunitinib—kidney cancer	0.000239	0.00141	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Sunitinib—kidney cancer	0.000239	0.00141	CcSEcCtD
Rosiglitazone—Anaemia—Vincristine—kidney cancer	0.000233	0.00137	CcSEcCtD
Rosiglitazone—Rash—Pazopanib—kidney cancer	0.000233	0.00137	CcSEcCtD
Rosiglitazone—Nausea—Temsirolimus—kidney cancer	0.000233	0.00137	CcSEcCtD
Rosiglitazone—Dermatitis—Pazopanib—kidney cancer	0.000233	0.00137	CcSEcCtD
Rosiglitazone—Back pain—Gemcitabine—kidney cancer	0.000232	0.00137	CcSEcCtD
Rosiglitazone—Headache—Pazopanib—kidney cancer	0.000232	0.00136	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000231	0.00136	CcSEcCtD
Rosiglitazone—Oedema—Dactinomycin—kidney cancer	0.000231	0.00136	CcSEcCtD
Rosiglitazone—Fluid retention—Doxorubicin—kidney cancer	0.000231	0.00136	CcSEcCtD
Rosiglitazone—Infection—Dactinomycin—kidney cancer	0.000229	0.00135	CcSEcCtD
Rosiglitazone—Oedema peripheral—Paclitaxel—kidney cancer	0.000227	0.00134	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Paclitaxel—kidney cancer	0.000227	0.00133	CcSEcCtD
Rosiglitazone—Leukopenia—Vincristine—kidney cancer	0.000226	0.00133	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Dactinomycin—kidney cancer	0.000226	0.00133	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000222	0.00131	CcSEcCtD
Rosiglitazone—Anaemia—Gemcitabine—kidney cancer	0.000222	0.0013	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Capecitabine—kidney cancer	0.00022	0.00129	CcSEcCtD
Rosiglitazone—Nausea—Pazopanib—kidney cancer	0.00022	0.00129	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000219	0.00129	CcSEcCtD
Rosiglitazone—Fatigue—Sorafenib—kidney cancer	0.000218	0.00129	CcSEcCtD
Rosiglitazone—Hypertension—Vincristine—kidney cancer	0.000218	0.00128	CcSEcCtD
Rosiglitazone—Erythema multiforme—Paclitaxel—kidney cancer	0.000218	0.00128	CcSEcCtD
Rosiglitazone—Constipation—Sorafenib—kidney cancer	0.000217	0.00128	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Doxorubicin—kidney cancer	0.000216	0.00127	CcSEcCtD
Rosiglitazone—Eye disorder—Paclitaxel—kidney cancer	0.000215	0.00127	CcSEcCtD
Rosiglitazone—Myalgia—Vincristine—kidney cancer	0.000215	0.00127	CcSEcCtD
Rosiglitazone—Weight increased—Capecitabine—kidney cancer	0.000215	0.00127	CcSEcCtD
Rosiglitazone—Leukopenia—Gemcitabine—kidney cancer	0.000215	0.00126	CcSEcCtD
Rosiglitazone—Cardiac disorder—Paclitaxel—kidney cancer	0.000214	0.00126	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Capecitabine—kidney cancer	0.000213	0.00126	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00021	0.00124	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00021	0.00124	CcSEcCtD
Rosiglitazone—Asthenia—Vinblastine—kidney cancer	0.00021	0.00124	CcSEcCtD
Rosiglitazone—Fatigue—Sunitinib—kidney cancer	0.00021	0.00124	CcSEcCtD
Rosiglitazone—Asthenia—Everolimus—kidney cancer	0.000209	0.00123	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000209	0.00123	CcSEcCtD
Rosiglitazone—Constipation—Sunitinib—kidney cancer	0.000208	0.00123	CcSEcCtD
Rosiglitazone—Immune system disorder—Paclitaxel—kidney cancer	0.000208	0.00123	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Capecitabine—kidney cancer	0.000208	0.00122	CcSEcCtD
Rosiglitazone—Hypertension—Gemcitabine—kidney cancer	0.000207	0.00122	CcSEcCtD
Rosiglitazone—Myocardial infarction—Capecitabine—kidney cancer	0.000207	0.00122	CcSEcCtD
Rosiglitazone—Pruritus—Everolimus—kidney cancer	0.000206	0.00122	CcSEcCtD
Rosiglitazone—Oedema—Vincristine—kidney cancer	0.000206	0.00121	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Vincristine—kidney cancer	0.000206	0.00121	CcSEcCtD
Rosiglitazone—Infection—Vincristine—kidney cancer	0.000205	0.00121	CcSEcCtD
Rosiglitazone—Arthralgia—Gemcitabine—kidney cancer	0.000204	0.0012	CcSEcCtD
Rosiglitazone—Myalgia—Gemcitabine—kidney cancer	0.000204	0.0012	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Doxorubicin—kidney cancer	0.000203	0.00119	CcSEcCtD
Rosiglitazone—Nervous system disorder—Vincristine—kidney cancer	0.000202	0.00119	CcSEcCtD
Rosiglitazone—Asthenia—Erlotinib—kidney cancer	0.000202	0.00119	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Vincristine—kidney cancer	0.000202	0.00119	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000202	0.00119	CcSEcCtD
Rosiglitazone—Urticaria—Sorafenib—kidney cancer	0.000201	0.00119	CcSEcCtD
Rosiglitazone—Malnutrition—Paclitaxel—kidney cancer	0.000201	0.00118	CcSEcCtD
Rosiglitazone—Diarrhoea—Vinblastine—kidney cancer	0.0002	0.00118	CcSEcCtD
Rosiglitazone—Diarrhoea—Everolimus—kidney cancer	0.0002	0.00118	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Capecitabine—kidney cancer	0.000199	0.00117	CcSEcCtD
Rosiglitazone—Pruritus—Erlotinib—kidney cancer	0.000199	0.00117	CcSEcCtD
Rosiglitazone—Fatigue—Dactinomycin—kidney cancer	0.000199	0.00117	CcSEcCtD
Rosiglitazone—Hepatic failure—Doxorubicin—kidney cancer	0.000196	0.00115	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Gemcitabine—kidney cancer	0.000196	0.00115	CcSEcCtD
Rosiglitazone—Oedema—Gemcitabine—kidney cancer	0.000196	0.00115	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000194	0.00114	CcSEcCtD
Rosiglitazone—Infection—Gemcitabine—kidney cancer	0.000194	0.00114	CcSEcCtD
Rosiglitazone—Back pain—Paclitaxel—kidney cancer	0.000194	0.00114	CcSEcCtD
Rosiglitazone—Dizziness—Vinblastine—kidney cancer	0.000194	0.00114	CcSEcCtD
Rosiglitazone—Dizziness—Everolimus—kidney cancer	0.000193	0.00114	CcSEcCtD
Rosiglitazone—Diarrhoea—Erlotinib—kidney cancer	0.000193	0.00113	CcSEcCtD
Rosiglitazone—Nervous system disorder—Gemcitabine—kidney cancer	0.000192	0.00113	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Gemcitabine—kidney cancer	0.000192	0.00113	CcSEcCtD
Rosiglitazone—Hepatitis—Capecitabine—kidney cancer	0.000189	0.00111	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000188	0.00111	CcSEcCtD
Rosiglitazone—Increased appetite—Doxorubicin—kidney cancer	0.000188	0.0011	CcSEcCtD
Rosiglitazone—Oedema peripheral—Capecitabine—kidney cancer	0.000186	0.0011	CcSEcCtD
Rosiglitazone—Dizziness—Erlotinib—kidney cancer	0.000186	0.0011	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Capecitabine—kidney cancer	0.000186	0.00109	CcSEcCtD
Rosiglitazone—Anaemia—Paclitaxel—kidney cancer	0.000185	0.00109	CcSEcCtD
Rosiglitazone—Rash—Everolimus—kidney cancer	0.000184	0.00108	CcSEcCtD
Rosiglitazone—Dermatitis—Everolimus—kidney cancer	0.000184	0.00108	CcSEcCtD
Rosiglitazone—Headache—Vinblastine—kidney cancer	0.000184	0.00108	CcSEcCtD
Rosiglitazone—Angioedema—Paclitaxel—kidney cancer	0.000183	0.00108	CcSEcCtD
Rosiglitazone—Headache—Everolimus—kidney cancer	0.000183	0.00108	CcSEcCtD
Rosiglitazone—Asthenia—Sorafenib—kidney cancer	0.000182	0.00107	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Doxorubicin—kidney cancer	0.000181	0.00106	CcSEcCtD
Rosiglitazone—Cardiac failure—Doxorubicin—kidney cancer	0.000181	0.00106	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Doxorubicin—kidney cancer	0.00018	0.00106	CcSEcCtD
Rosiglitazone—Leukopenia—Paclitaxel—kidney cancer	0.00018	0.00106	CcSEcCtD
Rosiglitazone—Pruritus—Sorafenib—kidney cancer	0.000179	0.00106	CcSEcCtD
Rosiglitazone—Erythema multiforme—Capecitabine—kidney cancer	0.000179	0.00105	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000178	0.00105	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Vincristine—kidney cancer	0.000178	0.00105	CcSEcCtD
Rosiglitazone—Fatigue—Vincristine—kidney cancer	0.000178	0.00105	CcSEcCtD
Rosiglitazone—Rash—Erlotinib—kidney cancer	0.000178	0.00105	CcSEcCtD
Rosiglitazone—Dermatitis—Erlotinib—kidney cancer	0.000177	0.00104	CcSEcCtD
Rosiglitazone—Eye disorder—Capecitabine—kidney cancer	0.000177	0.00104	CcSEcCtD
Rosiglitazone—Headache—Erlotinib—kidney cancer	0.000176	0.00104	CcSEcCtD
Rosiglitazone—Constipation—Vincristine—kidney cancer	0.000176	0.00104	CcSEcCtD
Rosiglitazone—Cardiac disorder—Capecitabine—kidney cancer	0.000176	0.00103	CcSEcCtD
Rosiglitazone—Asthenia—Sunitinib—kidney cancer	0.000175	0.00103	CcSEcCtD
Rosiglitazone—Nausea—Vinblastine—kidney cancer	0.000174	0.00102	CcSEcCtD
Rosiglitazone—Nausea—Everolimus—kidney cancer	0.000173	0.00102	CcSEcCtD
Rosiglitazone—Diarrhoea—Sorafenib—kidney cancer	0.000173	0.00102	CcSEcCtD
Rosiglitazone—Hypertension—Paclitaxel—kidney cancer	0.000173	0.00102	CcSEcCtD
Rosiglitazone—Pruritus—Sunitinib—kidney cancer	0.000172	0.00102	CcSEcCtD
Rosiglitazone—Immune system disorder—Capecitabine—kidney cancer	0.000171	0.00101	CcSEcCtD
Rosiglitazone—Arthralgia—Paclitaxel—kidney cancer	0.000171	0.00101	CcSEcCtD
Rosiglitazone—Myalgia—Paclitaxel—kidney cancer	0.000171	0.00101	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000169	0.000994	CcSEcCtD
Rosiglitazone—Fatigue—Gemcitabine—kidney cancer	0.000169	0.000993	CcSEcCtD
Rosiglitazone—Dizziness—Sorafenib—kidney cancer	0.000168	0.000986	CcSEcCtD
Rosiglitazone—Constipation—Gemcitabine—kidney cancer	0.000167	0.000985	CcSEcCtD
Rosiglitazone—Nausea—Erlotinib—kidney cancer	0.000167	0.000985	CcSEcCtD
Rosiglitazone—Diarrhoea—Sunitinib—kidney cancer	0.000167	0.000982	CcSEcCtD
Rosiglitazone—Asthenia—Dactinomycin—kidney cancer	0.000166	0.000975	CcSEcCtD
Rosiglitazone—Malnutrition—Capecitabine—kidney cancer	0.000165	0.00097	CcSEcCtD
Rosiglitazone—Oedema—Paclitaxel—kidney cancer	0.000164	0.000964	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Paclitaxel—kidney cancer	0.000164	0.000964	CcSEcCtD
Rosiglitazone—Infection—Paclitaxel—kidney cancer	0.000163	0.000958	CcSEcCtD
Rosiglitazone—Dizziness—Sunitinib—kidney cancer	0.000161	0.000949	CcSEcCtD
Rosiglitazone—Nervous system disorder—Paclitaxel—kidney cancer	0.000161	0.000946	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Paclitaxel—kidney cancer	0.00016	0.000944	CcSEcCtD
Rosiglitazone—Rash—Sorafenib—kidney cancer	0.00016	0.000941	CcSEcCtD
Rosiglitazone—Dermatitis—Sorafenib—kidney cancer	0.00016	0.00094	CcSEcCtD
Rosiglitazone—Back pain—Capecitabine—kidney cancer	0.000159	0.000938	CcSEcCtD
Rosiglitazone—Headache—Sorafenib—kidney cancer	0.000159	0.000935	CcSEcCtD
Rosiglitazone—Diarrhoea—Dactinomycin—kidney cancer	0.000158	0.00093	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Doxorubicin—kidney cancer	0.000158	0.000928	CcSEcCtD
Rosiglitazone—Rash—Sunitinib—kidney cancer	0.000154	0.000905	CcSEcCtD
Rosiglitazone—Dermatitis—Sunitinib—kidney cancer	0.000154	0.000904	CcSEcCtD
Rosiglitazone—Headache—Sunitinib—kidney cancer	0.000153	0.000899	CcSEcCtD
Rosiglitazone—Anaemia—Capecitabine—kidney cancer	0.000152	0.000896	CcSEcCtD
Rosiglitazone—Nausea—Sorafenib—kidney cancer	0.00015	0.000886	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000149	0.000879	CcSEcCtD
Rosiglitazone—Asthenia—Vincristine—kidney cancer	0.000148	0.000871	CcSEcCtD
Rosiglitazone—Leukopenia—Capecitabine—kidney cancer	0.000147	0.000868	CcSEcCtD
Rosiglitazone—Rash—Dactinomycin—kidney cancer	0.000145	0.000857	CcSEcCtD
Rosiglitazone—Nausea—Sunitinib—kidney cancer	0.000145	0.000853	CcSEcCtD
Rosiglitazone—Hypertension—Capecitabine—kidney cancer	0.000142	0.000837	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000142	0.000834	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000141	0.000833	CcSEcCtD
Rosiglitazone—Fatigue—Paclitaxel—kidney cancer	0.000141	0.000831	CcSEcCtD
Rosiglitazone—Diarrhoea—Vincristine—kidney cancer	0.000141	0.000831	CcSEcCtD
Rosiglitazone—Asthenia—Gemcitabine—kidney cancer	0.00014	0.000826	CcSEcCtD
Rosiglitazone—Myalgia—Capecitabine—kidney cancer	0.00014	0.000825	CcSEcCtD
Rosiglitazone—Arthralgia—Capecitabine—kidney cancer	0.00014	0.000825	CcSEcCtD
Rosiglitazone—Constipation—Paclitaxel—kidney cancer	0.00014	0.000825	CcSEcCtD
Rosiglitazone—Weight increased—Doxorubicin—kidney cancer	0.000139	0.000816	CcSEcCtD
Rosiglitazone—Pruritus—Gemcitabine—kidney cancer	0.000138	0.000815	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Doxorubicin—kidney cancer	0.000137	0.000809	CcSEcCtD
Rosiglitazone—Nausea—Dactinomycin—kidney cancer	0.000137	0.000807	CcSEcCtD
Rosiglitazone—Dizziness—Vincristine—kidney cancer	0.000136	0.000803	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000135	0.000793	CcSEcCtD
Rosiglitazone—Oedema—Capecitabine—kidney cancer	0.000134	0.000791	CcSEcCtD
Rosiglitazone—Diarrhoea—Gemcitabine—kidney cancer	0.000134	0.000788	CcSEcCtD
Rosiglitazone—Infection—Capecitabine—kidney cancer	0.000134	0.000786	CcSEcCtD
Rosiglitazone—Nervous system disorder—Capecitabine—kidney cancer	0.000132	0.000776	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Capecitabine—kidney cancer	0.000132	0.000775	CcSEcCtD
Rosiglitazone—Urticaria—Paclitaxel—kidney cancer	0.00013	0.000766	CcSEcCtD
Rosiglitazone—Rash—Vincristine—kidney cancer	0.00013	0.000765	CcSEcCtD
Rosiglitazone—Dermatitis—Vincristine—kidney cancer	0.00013	0.000765	CcSEcCtD
Rosiglitazone—Headache—Vincristine—kidney cancer	0.000129	0.000761	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000128	0.000756	CcSEcCtD
Rosiglitazone—Sinusitis—Doxorubicin—kidney cancer	0.000127	0.00075	CcSEcCtD
Rosiglitazone—Rash—Gemcitabine—kidney cancer	0.000123	0.000726	CcSEcCtD
Rosiglitazone—Dermatitis—Gemcitabine—kidney cancer	0.000123	0.000726	CcSEcCtD
Rosiglitazone—Headache—Gemcitabine—kidney cancer	0.000123	0.000722	CcSEcCtD
Rosiglitazone—Nausea—Vincristine—kidney cancer	0.000122	0.000721	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000122	0.000721	CcSEcCtD
Rosiglitazone—Hepatitis—Doxorubicin—kidney cancer	0.000122	0.000718	CcSEcCtD
Rosiglitazone—Oedema peripheral—Doxorubicin—kidney cancer	0.00012	0.000707	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Doxorubicin—kidney cancer	0.00012	0.000706	CcSEcCtD
Rosiglitazone—Asthenia—Paclitaxel—kidney cancer	0.000117	0.000692	CcSEcCtD
Rosiglitazone—Nausea—Gemcitabine—kidney cancer	0.000116	0.000684	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000116	0.000683	CcSEcCtD
Rosiglitazone—Fatigue—Capecitabine—kidney cancer	0.000116	0.000682	CcSEcCtD
Rosiglitazone—Pruritus—Paclitaxel—kidney cancer	0.000116	0.000682	CcSEcCtD
Rosiglitazone—Erythema multiforme—Doxorubicin—kidney cancer	0.000115	0.000679	CcSEcCtD
Rosiglitazone—Constipation—Capecitabine—kidney cancer	0.000115	0.000677	CcSEcCtD
Rosiglitazone—Eye disorder—Doxorubicin—kidney cancer	0.000114	0.000671	CcSEcCtD
Rosiglitazone—Cardiac disorder—Doxorubicin—kidney cancer	0.000113	0.000666	CcSEcCtD
Rosiglitazone—Diarrhoea—Paclitaxel—kidney cancer	0.000112	0.00066	CcSEcCtD
Rosiglitazone—Immune system disorder—Doxorubicin—kidney cancer	0.00011	0.000649	CcSEcCtD
Rosiglitazone—Dizziness—Paclitaxel—kidney cancer	0.000108	0.000638	CcSEcCtD
Rosiglitazone—Urticaria—Capecitabine—kidney cancer	0.000107	0.000629	CcSEcCtD
Rosiglitazone—Malnutrition—Doxorubicin—kidney cancer	0.000106	0.000625	CcSEcCtD
Rosiglitazone—Rash—Paclitaxel—kidney cancer	0.000103	0.000608	CcSEcCtD
Rosiglitazone—Dermatitis—Paclitaxel—kidney cancer	0.000103	0.000607	CcSEcCtD
Rosiglitazone—Back pain—Doxorubicin—kidney cancer	0.000103	0.000605	CcSEcCtD
Rosiglitazone—Headache—Paclitaxel—kidney cancer	0.000103	0.000604	CcSEcCtD
Rosiglitazone—Anaemia—Doxorubicin—kidney cancer	9.81e-05	0.000578	CcSEcCtD
Rosiglitazone—Nausea—Paclitaxel—kidney cancer	9.73e-05	0.000573	CcSEcCtD
Rosiglitazone—Asthenia—Capecitabine—kidney cancer	9.64e-05	0.000568	CcSEcCtD
Rosiglitazone—Pruritus—Capecitabine—kidney cancer	9.51e-05	0.00056	CcSEcCtD
Rosiglitazone—Leukopenia—Doxorubicin—kidney cancer	9.5e-05	0.000559	CcSEcCtD
Rosiglitazone—Diarrhoea—Capecitabine—kidney cancer	9.19e-05	0.000541	CcSEcCtD
Rosiglitazone—Hypertension—Doxorubicin—kidney cancer	9.16e-05	0.00054	CcSEcCtD
Rosiglitazone—Arthralgia—Doxorubicin—kidney cancer	9.04e-05	0.000532	CcSEcCtD
Rosiglitazone—Myalgia—Doxorubicin—kidney cancer	9.04e-05	0.000532	CcSEcCtD
Rosiglitazone—Dizziness—Capecitabine—kidney cancer	8.89e-05	0.000523	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Doxorubicin—kidney cancer	8.66e-05	0.00051	CcSEcCtD
Rosiglitazone—Oedema—Doxorubicin—kidney cancer	8.66e-05	0.00051	CcSEcCtD
Rosiglitazone—Infection—Doxorubicin—kidney cancer	8.61e-05	0.000507	CcSEcCtD
Rosiglitazone—Nervous system disorder—Doxorubicin—kidney cancer	8.5e-05	0.0005	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Doxorubicin—kidney cancer	8.48e-05	0.000499	CcSEcCtD
Rosiglitazone—Rash—Capecitabine—kidney cancer	8.47e-05	0.000499	CcSEcCtD
Rosiglitazone—Dermatitis—Capecitabine—kidney cancer	8.47e-05	0.000498	CcSEcCtD
Rosiglitazone—Headache—Capecitabine—kidney cancer	8.42e-05	0.000496	CcSEcCtD
Rosiglitazone—Nausea—Capecitabine—kidney cancer	7.98e-05	0.00047	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	7.89e-05	0.000465	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Doxorubicin—kidney cancer	7.48e-05	0.00044	CcSEcCtD
Rosiglitazone—Fatigue—Doxorubicin—kidney cancer	7.47e-05	0.00044	CcSEcCtD
Rosiglitazone—Constipation—Doxorubicin—kidney cancer	7.41e-05	0.000436	CcSEcCtD
Rosiglitazone—Urticaria—Doxorubicin—kidney cancer	6.88e-05	0.000405	CcSEcCtD
Rosiglitazone—Asthenia—Doxorubicin—kidney cancer	6.22e-05	0.000366	CcSEcCtD
Rosiglitazone—Pruritus—Doxorubicin—kidney cancer	6.13e-05	0.000361	CcSEcCtD
Rosiglitazone—Diarrhoea—Doxorubicin—kidney cancer	5.93e-05	0.000349	CcSEcCtD
Rosiglitazone—Dizziness—Doxorubicin—kidney cancer	5.73e-05	0.000337	CcSEcCtD
Rosiglitazone—Rash—Doxorubicin—kidney cancer	5.46e-05	0.000322	CcSEcCtD
Rosiglitazone—Dermatitis—Doxorubicin—kidney cancer	5.46e-05	0.000321	CcSEcCtD
Rosiglitazone—Headache—Doxorubicin—kidney cancer	5.43e-05	0.00032	CcSEcCtD
Rosiglitazone—Nausea—Doxorubicin—kidney cancer	5.15e-05	0.000303	CcSEcCtD
Rosiglitazone—CYP2D6—Metabolism—GPC3—kidney cancer	1.57e-05	0.000255	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—MYC—kidney cancer	1.56e-05	0.000254	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—GSTP1—kidney cancer	1.55e-05	0.000253	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GPC3—kidney cancer	1.55e-05	0.000253	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.54e-05	0.000251	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—BCHE—kidney cancer	1.54e-05	0.000251	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CA2—kidney cancer	1.52e-05	0.000248	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—SLC5A5—kidney cancer	1.52e-05	0.000248	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.52e-05	0.000248	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPAT—kidney cancer	1.52e-05	0.000248	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CA2—kidney cancer	1.51e-05	0.000246	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—MAPK3—kidney cancer	1.51e-05	0.000246	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.5e-05	0.000244	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—SCARB1—kidney cancer	1.49e-05	0.000242	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALAD—kidney cancer	1.48e-05	0.000242	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ACHE—kidney cancer	1.48e-05	0.000242	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GSTT1—kidney cancer	1.48e-05	0.000242	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.48e-05	0.000242	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.48e-05	0.000241	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PGK1—kidney cancer	1.48e-05	0.000241	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALAD—kidney cancer	1.47e-05	0.00024	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ABCB1—kidney cancer	1.47e-05	0.00024	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—SLC2A1—kidney cancer	1.47e-05	0.000239	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.45e-05	0.000236	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—LDHB—kidney cancer	1.45e-05	0.000236	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PSMD7—kidney cancer	1.44e-05	0.000235	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.44e-05	0.000234	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—MAPK1—kidney cancer	1.43e-05	0.000234	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—GSTM1—kidney cancer	1.43e-05	0.000233	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.42e-05	0.000232	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.42e-05	0.000231	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.41e-05	0.00023	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—FH—kidney cancer	1.41e-05	0.00023	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APRT—kidney cancer	1.41e-05	0.00023	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CA9—kidney cancer	1.41e-05	0.000229	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—SCARB1—kidney cancer	1.4e-05	0.000229	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.4e-05	0.000229	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CA9—kidney cancer	1.4e-05	0.000228	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.4e-05	0.000228	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS1—kidney cancer	1.39e-05	0.000227	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.38e-05	0.000225	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.37e-05	0.000224	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—BCHE—kidney cancer	1.37e-05	0.000223	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.37e-05	0.000223	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	1.36e-05	0.000222	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PSMD7—kidney cancer	1.36e-05	0.000222	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.36e-05	0.000221	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PGK1—kidney cancer	1.36e-05	0.000221	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—KRAS—kidney cancer	1.35e-05	0.000221	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—CYP1A1—kidney cancer	1.35e-05	0.000221	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—SLC5A5—kidney cancer	1.35e-05	0.00022	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PGK1—kidney cancer	1.35e-05	0.00022	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.35e-05	0.00022	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—LDHB—kidney cancer	1.33e-05	0.000217	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GPC3—kidney cancer	1.33e-05	0.000216	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—LDHB—kidney cancer	1.32e-05	0.000215	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—SLC2A1—kidney cancer	1.3e-05	0.000213	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—BCHE—kidney cancer	1.29e-05	0.000211	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CA2—kidney cancer	1.29e-05	0.00021	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	1.29e-05	0.00021	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—SLC5A5—kidney cancer	1.28e-05	0.000208	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.27e-05	0.000206	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALAD—kidney cancer	1.26e-05	0.000205	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CA9—kidney cancer	1.26e-05	0.000205	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.24e-05	0.000202	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—SLC2A1—kidney cancer	1.23e-05	0.000201	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	1.23e-05	0.0002	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.23e-05	0.0002	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.23e-05	0.0002	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GSTP1—kidney cancer	1.22e-05	0.000199	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.2e-05	0.000196	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CRABP1—kidney cancer	1.2e-05	0.000195	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CRABP1—kidney cancer	1.19e-05	0.000194	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ABCB1—kidney cancer	1.16e-05	0.000189	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CA9—kidney cancer	1.15e-05	0.000188	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PGK1—kidney cancer	1.15e-05	0.000188	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.15e-05	0.000188	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CA9—kidney cancer	1.14e-05	0.000187	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—LDHB—kidney cancer	1.13e-05	0.000184	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GSTM1—kidney cancer	1.12e-05	0.000183	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.12e-05	0.000182	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ITPR2—kidney cancer	1.11e-05	0.000181	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.11e-05	0.000181	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ITPR2—kidney cancer	1.11e-05	0.00018	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.1e-05	0.00018	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GSTP1—kidney cancer	1.09e-05	0.000177	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CRABP1—kidney cancer	1.07e-05	0.000174	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.07e-05	0.000174	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CYP1A1—kidney cancer	1.07e-05	0.000174	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ABCB1—kidney cancer	1.03e-05	0.000168	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GSTP1—kidney cancer	1.03e-05	0.000168	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.02e-05	0.000167	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.02e-05	0.000166	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTT1—kidney cancer	1.01e-05	0.000165	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ACHE—kidney cancer	1.01e-05	0.000165	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—POMC—kidney cancer	1.01e-05	0.000164	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ACHE—kidney cancer	1.01e-05	0.000164	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTT1—kidney cancer	1.01e-05	0.000164	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GSTM1—kidney cancer	1e-05	0.000163	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ITPR2—kidney cancer	9.92e-06	0.000162	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CRABP1—kidney cancer	9.82e-06	0.00016	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CA9—kidney cancer	9.78e-06	0.00016	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ABCB1—kidney cancer	9.74e-06	0.000159	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CRABP1—kidney cancer	9.73e-06	0.000159	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SCARB1—kidney cancer	9.6e-06	0.000156	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.56e-06	0.000156	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SCARB1—kidney cancer	9.54e-06	0.000156	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS1—kidney cancer	9.5e-06	0.000155	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CYP1A1—kidney cancer	9.48e-06	0.000155	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GSTM1—kidney cancer	9.45e-06	0.000154	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS1—kidney cancer	9.45e-06	0.000154	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PSMD7—kidney cancer	9.32e-06	0.000152	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PSMD7—kidney cancer	9.26e-06	0.000151	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—RAF1—kidney cancer	9.23e-06	0.000151	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.15e-06	0.000149	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ITPR2—kidney cancer	9.13e-06	0.000149	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTT1—kidney cancer	9.05e-06	0.000148	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ACHE—kidney cancer	9.05e-06	0.000148	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ITPR2—kidney cancer	9.05e-06	0.000148	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CYP1A1—kidney cancer	8.96e-06	0.000146	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—BCHE—kidney cancer	8.83e-06	0.000144	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—BCHE—kidney cancer	8.78e-06	0.000143	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.75e-06	0.000143	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SLC5A5—kidney cancer	8.72e-06	0.000142	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SLC5A5—kidney cancer	8.67e-06	0.000141	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SCARB1—kidney cancer	8.57e-06	0.00014	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS1—kidney cancer	8.48e-06	0.000138	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SLC2A1—kidney cancer	8.42e-06	0.000137	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SLC2A1—kidney cancer	8.38e-06	0.000137	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.34e-06	0.000136	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ACHE—kidney cancer	8.32e-06	0.000136	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTT1—kidney cancer	8.32e-06	0.000136	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CRABP1—kidney cancer	8.32e-06	0.000136	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PSMD7—kidney cancer	8.31e-06	0.000136	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—IL2—kidney cancer	8.27e-06	0.000135	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTT1—kidney cancer	8.25e-06	0.000135	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ACHE—kidney cancer	8.25e-06	0.000135	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.17e-06	0.000133	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.13e-06	0.000133	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTGS2—kidney cancer	8.05e-06	0.000131	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	7.99e-06	0.00013	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—POMC—kidney cancer	7.94e-06	0.00013	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—BCHE—kidney cancer	7.88e-06	0.000129	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SCARB1—kidney cancer	7.88e-06	0.000128	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SCARB1—kidney cancer	7.81e-06	0.000127	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS1—kidney cancer	7.8e-06	0.000127	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SLC5A5—kidney cancer	7.79e-06	0.000127	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.79e-06	0.000127	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ITPR2—kidney cancer	7.73e-06	0.000126	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS1—kidney cancer	7.73e-06	0.000126	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MAPK3—kidney cancer	7.71e-06	0.000126	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PSMD7—kidney cancer	7.65e-06	0.000125	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PSMD7—kidney cancer	7.58e-06	0.000124	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SLC2A1—kidney cancer	7.52e-06	0.000123	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MYC—kidney cancer	7.5e-06	0.000122	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.3e-06	0.000119	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—BCHE—kidney cancer	7.25e-06	0.000118	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—BCHE—kidney cancer	7.19e-06	0.000117	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SLC5A5—kidney cancer	7.16e-06	0.000117	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.13e-06	0.000116	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.13e-06	0.000116	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SLC5A5—kidney cancer	7.1e-06	0.000116	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.09e-06	0.000116	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—POMC—kidney cancer	7.07e-06	0.000115	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTT1—kidney cancer	7.05e-06	0.000115	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ACHE—kidney cancer	7.05e-06	0.000115	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—VEGFA—kidney cancer	7.03e-06	0.000115	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTP1—kidney cancer	7.03e-06	0.000115	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTEN—kidney cancer	7.02e-06	0.000114	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTP1—kidney cancer	6.99e-06	0.000114	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SLC2A1—kidney cancer	6.92e-06	0.000113	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SLC2A1—kidney cancer	6.86e-06	0.000112	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—POMC—kidney cancer	6.68e-06	0.000109	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SCARB1—kidney cancer	6.67e-06	0.000109	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.65e-06	0.000108	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—MAPK3—kidney cancer	6.65e-06	0.000108	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ABCB1—kidney cancer	6.65e-06	0.000108	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ABCB1—kidney cancer	6.61e-06	0.000108	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS1—kidney cancer	6.61e-06	0.000108	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PSMD7—kidney cancer	6.48e-06	0.000106	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTM1—kidney cancer	6.46e-06	0.000105	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTM1—kidney cancer	6.42e-06	0.000105	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.36e-06	0.000104	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTGS2—kidney cancer	6.34e-06	0.000103	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—MAPK1—kidney cancer	6.33e-06	0.000103	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTP1—kidney cancer	6.27e-06	0.000102	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—BCHE—kidney cancer	6.14e-06	0.0001	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP1A1—kidney cancer	6.12e-06	9.98e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP1A1—kidney cancer	6.09e-06	9.93e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC5A5—kidney cancer	6.07e-06	9.89e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—KRAS—kidney cancer	5.98e-06	9.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ABCB1—kidney cancer	5.94e-06	9.68e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC2A1—kidney cancer	5.86e-06	9.56e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.8e-06	9.46e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTP1—kidney cancer	5.77e-06	9.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTM1—kidney cancer	5.76e-06	9.4e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTP1—kidney cancer	5.72e-06	9.33e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.68e-06	9.27e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTGS2—kidney cancer	5.64e-06	9.19e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTEN—kidney cancer	5.52e-06	9.01e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CA—kidney cancer	5.49e-06	8.96e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP1A1—kidney cancer	5.46e-06	8.91e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ABCB1—kidney cancer	5.46e-06	8.91e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ABCB1—kidney cancer	5.41e-06	8.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS2—kidney cancer	5.33e-06	8.69e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TP53—kidney cancer	5.31e-06	8.67e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTM1—kidney cancer	5.3e-06	8.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTM1—kidney cancer	5.26e-06	8.57e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.03e-06	8.2e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP1A1—kidney cancer	5.03e-06	8.2e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5e-06	8.15e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.98e-06	8.12e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.96e-06	8.09e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CA—kidney cancer	4.95e-06	8.07e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTEN—kidney cancer	4.91e-06	8.02e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTP1—kidney cancer	4.89e-06	7.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTEN—kidney cancer	4.65e-06	7.58e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ABCB1—kidney cancer	4.63e-06	7.54e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—POMC—kidney cancer	4.56e-06	7.44e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—POMC—kidney cancer	4.54e-06	7.4e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTM1—kidney cancer	4.49e-06	7.32e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.49e-06	7.32e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP1A1—kidney cancer	4.26e-06	6.94e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.09e-06	6.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—POMC—kidney cancer	4.07e-06	6.64e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CA—kidney cancer	3.9e-06	6.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—POMC—kidney cancer	3.75e-06	6.11e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—POMC—kidney cancer	3.71e-06	6.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS2—kidney cancer	3.64e-06	5.94e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS2—kidney cancer	3.62e-06	5.9e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.5e-06	5.7e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CA—kidney cancer	3.47e-06	5.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CA—kidney cancer	3.28e-06	5.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS2—kidney cancer	3.25e-06	5.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTEN—kidney cancer	3.17e-06	5.18e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—POMC—kidney cancer	3.17e-06	5.18e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTEN—kidney cancer	3.16e-06	5.15e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS2—kidney cancer	2.99e-06	4.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS2—kidney cancer	2.96e-06	4.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTEN—kidney cancer	2.83e-06	4.62e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTEN—kidney cancer	2.61e-06	4.25e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTEN—kidney cancer	2.58e-06	4.21e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS2—kidney cancer	2.53e-06	4.13e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.24e-06	3.65e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CA—kidney cancer	2.23e-06	3.63e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTEN—kidney cancer	2.21e-06	3.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CA—kidney cancer	2e-06	3.26e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.84e-06	3e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.82e-06	2.97e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.56e-06	2.54e-05	CbGpPWpGaD
